Anti-inflammatory nutraceuticals and herbal medicines for the management of metabolic syndrome

George Q. Li; Ka H. Wong; Antony Kam; Xian Zhou; Eshaifol A. Omar; Ali Alqahtani; Kong M. Li; Valentina Razmovski-Naumovski; Kelvin Chan

doi:10.1201/b12696-28

Anti-inflammatory nutraceuticals and herbal medicines for the management of metabolic syndrome

George Q. Li, Ka H. Wong, Antony Kam, Xian Zhou, Eshaifol A. Omar, Ali Alqahtani, Kong M. Li, Valentina Razmovski-Naumovski, Kelvin Chan

Research output: Chapter in Book / Conference Paper › Chapter

Abstract

Metabolic syndrome, previously known as syndrome X and insulin resistance syndrome, refers to a constellation of disorders including central obesity, insulin resistance, glucose intolerance, dyslipidemia, and hypertension. These risk factors have been linked to an increased probability of cardiovascular diseases and type 2 diabetes mellitus. The World Health Organization (WHO) estimates that by 2015, approximately 2.3 billion adults worldwide will be overweight, and more than 700 million adults will be obese (WHO 2006). Additionally, the global prevalence of type 2 diabetes will rise to 336 million by 2030 (International Diabetes Foundation 2009).

Original language	English
Title of host publication	Chronic Inflammation: Molecular Pathophysiology, Nutritional and Therapeutic Interventions
Editors	Sashwati Roy, Debasis Bagchi, Siba P. Raychaudhuri
Place of Publication	U.S.A.
Publisher	CRC Press
Pages	337-350
Number of pages	14
ISBN (Electronic)	9781439872154
ISBN (Print)	9781439872116
DOIs	https://doi.org/10.1201/b12696-28
Publication status	Published - 2012

Keywords

traditional Chinese medicine
metabolic syndrome

Access to Document

10.1201/b12696-28

Cite this

Li, G. Q., Wong, K. H., Kam, A., Zhou, X., Omar, E. A., Alqahtani, A., Li, K. M., Razmovski-Naumovski, V., & Chan, K. (2012). Anti-inflammatory nutraceuticals and herbal medicines for the management of metabolic syndrome. In S. Roy, D. Bagchi, & S. P. Raychaudhuri (Eds.), Chronic Inflammation: Molecular Pathophysiology, Nutritional and Therapeutic Interventions (pp. 337-350). CRC Press. https://doi.org/10.1201/b12696-28

@inbook{e26856bfb35241e88f3d032049a73075,

title = "Anti-inflammatory nutraceuticals and herbal medicines for the management of metabolic syndrome",

abstract = "Metabolic syndrome, previously known as syndrome X and insulin resistance syndrome, refers to a constellation of disorders including central obesity, insulin resistance, glucose intolerance, dyslipidemia, and hypertension. These risk factors have been linked to an increased probability of cardiovascular diseases and type 2 diabetes mellitus. The World Health Organization (WHO) estimates that by 2015, approximately 2.3 billion adults worldwide will be overweight, and more than 700 million adults will be obese (WHO 2006). Additionally, the global prevalence of type 2 diabetes will rise to 336 million by 2030 (International Diabetes Foundation 2009).",

keywords = "traditional Chinese medicine, metabolic syndrome",

author = "Li, {George Q.} and Wong, {Ka H.} and Antony Kam and Xian Zhou and Omar, {Eshaifol A.} and Ali Alqahtani and Li, {Kong M.} and Valentina Razmovski-Naumovski and Kelvin Chan",

year = "2012",

doi = "10.1201/b12696-28",

language = "English",

isbn = "9781439872116",

pages = "337--350",

editor = "Sashwati Roy and Debasis Bagchi and Raychaudhuri, {Siba P.}",

booktitle = "Chronic Inflammation: Molecular Pathophysiology, Nutritional and Therapeutic Interventions",

publisher = "CRC Press",

}

Li, GQ, Wong, KH, Kam, A, Zhou, X, Omar, EA, Alqahtani, A, Li, KM, Razmovski-Naumovski, V & Chan, K 2012, Anti-inflammatory nutraceuticals and herbal medicines for the management of metabolic syndrome. in S Roy, D Bagchi & SP Raychaudhuri (eds), Chronic Inflammation: Molecular Pathophysiology, Nutritional and Therapeutic Interventions. CRC Press, U.S.A., pp. 337-350. https://doi.org/10.1201/b12696-28

Anti-inflammatory nutraceuticals and herbal medicines for the management of metabolic syndrome. / Li, George Q.; Wong, Ka H.; Kam, Antony et al.
Chronic Inflammation: Molecular Pathophysiology, Nutritional and Therapeutic Interventions. ed. / Sashwati Roy; Debasis Bagchi; Siba P. Raychaudhuri. U.S.A.: CRC Press, 2012. p. 337-350.

Research output: Chapter in Book / Conference Paper › Chapter

TY - CHAP

T1 - Anti-inflammatory nutraceuticals and herbal medicines for the management of metabolic syndrome

AU - Li, George Q.

AU - Wong, Ka H.

AU - Kam, Antony

AU - Zhou, Xian

AU - Omar, Eshaifol A.

AU - Alqahtani, Ali

AU - Li, Kong M.

AU - Razmovski-Naumovski, Valentina

AU - Chan, Kelvin

PY - 2012

Y1 - 2012

N2 - Metabolic syndrome, previously known as syndrome X and insulin resistance syndrome, refers to a constellation of disorders including central obesity, insulin resistance, glucose intolerance, dyslipidemia, and hypertension. These risk factors have been linked to an increased probability of cardiovascular diseases and type 2 diabetes mellitus. The World Health Organization (WHO) estimates that by 2015, approximately 2.3 billion adults worldwide will be overweight, and more than 700 million adults will be obese (WHO 2006). Additionally, the global prevalence of type 2 diabetes will rise to 336 million by 2030 (International Diabetes Foundation 2009).

AB - Metabolic syndrome, previously known as syndrome X and insulin resistance syndrome, refers to a constellation of disorders including central obesity, insulin resistance, glucose intolerance, dyslipidemia, and hypertension. These risk factors have been linked to an increased probability of cardiovascular diseases and type 2 diabetes mellitus. The World Health Organization (WHO) estimates that by 2015, approximately 2.3 billion adults worldwide will be overweight, and more than 700 million adults will be obese (WHO 2006). Additionally, the global prevalence of type 2 diabetes will rise to 336 million by 2030 (International Diabetes Foundation 2009).

KW - traditional Chinese medicine

KW - metabolic syndrome

UR - http://handle.uws.edu.au:8081/1959.7/520047

U2 - 10.1201/b12696-28

DO - 10.1201/b12696-28

M3 - Chapter

SN - 9781439872116

SP - 337

EP - 350

BT - Chronic Inflammation: Molecular Pathophysiology, Nutritional and Therapeutic Interventions

A2 - Roy, Sashwati

A2 - Bagchi, Debasis

A2 - Raychaudhuri, Siba P.

PB - CRC Press

CY - U.S.A.

ER -

Anti-inflammatory nutraceuticals and herbal medicines for the management of metabolic syndrome

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this